capravirine: Clinical Trials

4 completed, 2 suspended. 6 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 4, Suspended 2

Follow capravirine: new trials by email Literature Review of capravirine trials Research Report on capravirine

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens capravirine, Kaletra, 2 NRTIs - HIV Infections	Phase 2	Completed	Pfizer	300	2003-01-01	2007-10-10
Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen Capravirine - Human Immunodeficiency Virus	Phase 2	Completed	Pfizer	179	2002-08-01	2011-05-10
A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments Capravirine, Nelfinavir mesylate - HIV Infections	Phase 2	Completed	Agouron Pharmaceuticals	350	2000-02-01	2005-06-24
Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy Capravirine, Nelfinavir mesylate - HIV Infections	Phase 2	Completed	Agouron Pharmaceuticals	75	2000-01-01	2005-06-24
Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections	Phase 2	Suspended	Agouron Pharmaceuticals	30	1999-11-01	2005-06-24
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections	Phase 2	Suspended	Agouron Pharmaceuticals	350	1999-08-01	2005-06-24

Conditions studied

HIV Infections (6)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Disease Progression (1)

Sponsors

Agouron Pharmaceuticals (4)  ·  Pfizer (2)

Countries

United States (5)  ·  Dominican Republic (2)  ·  Puerto Rico (2)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  South Africa (1)  ·  Spain (1)